WHO ICTRP trial
A 12 weeks study to check whether Dermapen 4™ microneedling device with MG-CLR…
CTRI/2024/08/072306 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/08/072306 |
|---|---|
| Public title | A 12 weeks study to check whether Dermapen 4™ microneedling device with MG-CLR serum reduces acne. |
| Scientific title | A full face, baseline controlled study to evaluate the efficacy of Dermapen 4™ microneedling device in conjunction with MG-CLR serum for acne treatment over 12 weeks. - NIL |
| Primary sponsor | Equipmed USA LLC |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | United States of America;India |
| Interventions | Intervention1: Dermapen 4™ microneedling device with MG-CLR serum: Treatment using Dermapen 4™ microneedling device with MG-CLR serum will be provided at baseline, week 2, week 4 and week 6 to evaluate reduction in facial acne severity… |
| Registration date | Dec 8, 2024 |
| Target size | 55 |
| Secondary IDs | SKIN/EMAC/2024-01 version 1.1 dated 19 Jul 2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: